Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Colistinvs. the combination of colistin and rifampicin for the treatment of carbapenem-resistantAcinetobacter baumanniiventilator-associated pneumonia
2012
Food-grade TiO2 impairs intestinal and systemic immune homeostasis, initiates preneoplastic lesions and promotes aberrant crypt development in the rat colon
2017 Standout
Cytokines in inflammatory bowel disease
2014 Standout
ROS stress in cancer cells and therapeutic implications
2004 Standout
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Ulcerative Colitis
2011 Standout
A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis
2003
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Suppression of inflammation in ulcerative colitis by interferon-β-1a is accompanied by inhibition of IL-13 production
2010
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
2015 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages after chemotherapy with 5-fluorouracil, doxorubicin and cyclophosphamide
2010
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
A threshold concept for cancer therapy
2000
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
In vivo metabolism of 4-fluorobenzoic acid [(5-nitro-2-furanyl) methylene] hydrazide in rats
2000
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
The down side of glucocorticoid receptor regulation
1992
Simple high‐performance liquid chromatographic assay for melphalan in perfusate, rat liver and tumour tissue
2003
Antioxidant inhibitors for cancer therapy
1998
First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry
2005
Rapid determination of the anti-cancer drug chlorambucil (Leukeran™) and its phenyl acetic acid mustard metabolite in human serum and plasma by automated solid-phase extraction and liquid chromatography–tandem mass spectrometry
1999
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
New therapies for inflammatory bowel disease: from the bench to the bedside
2011
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Qualitative study of in vivo melphalan adduct formation in the rat by miniaturized column‐switching liquid chromatography coupled with electrospray mass spectrometry
2003
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
TLR Agonists as Adjuvants for Cancer Vaccines
2017
Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications
2006
Hormone receptors in malignancy
1992
Medical therapy for ulcerative colitis 2004
2004
Treatment of hepatitis C
2005
Analysis of anticancer drugs: A review
2011 Standout
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study
2007 Standout
Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin
1996
PROTAC targeted protein degraders: the past is prologue
2022 Standout
The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
2006
Immunomodulatory functions of type I interferons
2012
Ulcerative colitis
2020 Standout
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
Herb-Drug Interactions
2005 Standout
Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials
2001
Free radicals and antioxidants in chemotherapyinduced toxicity
1997
Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study
2003
New targets for mucosal healing and therapy in inflammatory bowel diseases
2013
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
ROS and the DNA damage response in cancer
2018 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Alkylation of DNA by melphalan: investigation of capillary liquid chromatography–electrospray ionization tandem mass spectrometry in the study of the adducts at the nucleoside level
2003
How antibiotics kill bacteria: from targets to networks
2010 Standout
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
2014
High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusions
1995
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness
2004
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Cortisol in teleosts: dynamics, mechanisms of action, and metabolic regulation
1999 Standout
Biological Activities of Hydrazone Derivatives
2007 Standout
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases
2013
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
A randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitis
2003
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption
2008
mTOR inhibitor INK128 attenuates dextran sodium sulfate‐induced colitis by promotion of MDSCs on Treg cell expansion
2018
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Amino Acid Variations in Hepatitis C Virus P7 and Sensitivity to Antiviral Combination Therapy with Amantadine in Chronic Hepatitis C
2006
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
2007
ETCM: an encyclopaedia of traditional Chinese medicine
2018 Standout
Chlorambucil-Adducts in DNA Analyzed at the Oligonucleotide Level Using HPLC-ESI MS
2009
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients
2012
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Locoregional cancer treatment with magnetic drug targeting.
2000
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions
2015 Standout
Works of E. Musch being referenced
Lipid Peroxides in the Polychemotherapy of Cancer Patients
1994
Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma
1989
Successful Treatment of Steroid Refractory Active Ulcerative Colitis with Natural Interferon-β - an Open Long-Term Trial
2007
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma—Lack of a positive correlation between receptor levels and clinical responsiveness
1990
Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity
2012
Randomized, controlled trial with IFN-α combined with ribavirin with and without amantadine sulphate in non-responders with chronic hepatitis C
2003
Interferon-β-1a for the Treatment of Steroid-Refractory Ulcerative Colitis: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
Induction and maintenance of clinical remission by interferon‐β in patients with steroid‐refractory active ulcerative colitis—an open long‐term pilot trial
2002
Studies on the pharmacokinetics of chlorambucl and prednimustine in patients using a new high-performance liquid chromatographic assay
1989
Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
1999
Determination of isoniazid, acetylisoniazid, acetylhydrazine and diacetylhydrazine in biological fluids by high-performance liquid chromatography
1985
Pharmacokinetics of oral and intravenous rifampicin during chronic administration
1985
A sensitive high-performance liquid chromatographic assay for melphalan and its hydrolysis products in blood and plasma
1988
[Local treatment of malignant pleural effusion in gynecologic tumors].
1990
Influence of the enzyme induction by rifampicin on its presystemic metabolism
1987